| 2022-03 | A pH-and Bioreducible Cationic Copolymer with Amino Acids and Piperazines for Adenovirus Delivery | 윤채옥 |
| 2015-05 | pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis | 윤채옥 |
| 2019-10 | Physically crosslinked injectable hydrogels for long-term delivery of oncolytic adenoviruses for cancer treatment | 윤채옥 |
| 2021-01 | Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic | 윤채옥 |
| 2015-12 | Polymeric oncolytic adenovirus for cancer gene therapy | 윤채옥 |
| 2022-02 | Polymeric Systems for Cancer Immunotherapy: A Review | 윤채옥 |
| 2021-12 | Polypeptide-Based K+Ionophore as a Strong Immunogenic Cell Death Inducer for Cancer Immunotherapy | 윤채옥 |
| 2015-11 | Potent and long-term antiangiogenic efficacy mediated by FP3-expressing oncolytic adenovirus | 윤채옥 |
| 2015-12 | Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model | 윤채옥 |
| 2018-01 | Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer | 윤채옥 |
| 2018-05 | Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues | 윤채옥 |
| 2012-08 | A proteoliposome containing apolipoprotein A-I mutant (V156K) enhances rapid tumor regression activity of human origin oncolytic adenovirus in tumor-bearing zebrafish and mice | 윤채옥 |
| 2015-08 | QUANTITATIVE IMPACT OF IMMUNOMODULATION VERSUS ONCOLYSIS WITH CYTOKINE-EXPRESSING VIRUS THERAPEUTICS | 윤채옥 |
| 2013-02 | Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers | 윤채옥 |
| 2016-06 | Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy | 윤채옥 |
| 2013-03 | Regulation of the Cyclin-dependent Kinase Inhibitor 1A Gene (CDKN1A) by the Repressor BOZF1 through Inhibition of p53 Acetylation and Transcription Factor Sp1 Binding | 윤채옥 |
| 2019-11 | Regulatory T Cells Induce Metastasis by Increasing Tgf-β and Enhancing the Epithelial–Mesenchymal Transition | 윤채옥 |
| 2019-05 | Relaxin gene therapy: A promising new treatment option for various diseases with aberrant fibrosis or irregular angiogenesis | 윤채옥 |
| 2012-09 | Relaxin-Expressing Adenovirus Decreases Collagen Synthesis and Up-Regulates Matrix Metalloproteinase Expression in Keloid Fibroblasts: In Vitro Experiments | 윤채옥 |
| 2020-08 | Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade | 윤채옥 |
| 2017-02 | Relevance of mortalin to cancer cell stemness and cancer therapy | 윤채옥 |
| 2012-11 | A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy | 윤채옥 |
| 2011-11 | RGD peptide-modified adenovirus expressing hepatocyte growth factor and X-linked inhibitor of apoptosis improves islet transplantation | 윤채옥 |
| 2014-07 | Role of Promyelocytic Leukemia Zinc Finger (PLZF) in Cell Proliferation and Cyclin-dependent Kinase Inhibitor 1A (p21WAF/CDKN1A) Gene Repression | 윤채옥 |
| 2021-04 | The role of viral infectivity in oncolytic virotherapy outcomes: A mathematical study | 윤채옥 |
| 2012-10 | S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma | 윤채옥 |
| 2012-10 | S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma | 윤채옥 |
| 2017-03 | Safety profile of EGFR-targeted hybrid vector system composed of PAMAM dendrimer and oncolytic adenovirus | 윤채옥 |
| 2015-01 | Safety Profiles and Antitumor Efficacy of Oncolytic Adenovirus Coated with Bioreducible Polymer in the Treatment of a CAR Negative Tumor Model | 윤채옥 |
| 2017-07 | Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression | 윤채옥 |
